GANX Gain Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $45.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $51.5K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $5.1K |
| 2024-Q1 | $115.8K | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $85.2K | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$252.6K8 buy days
Sold$5.1K2 sell days
Net insider flow+$247.5Knet buying · 5 years
Latest trade2024-08-09Islam Khalid
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2024-08-09 | Buy | Islam Khalid | Chair | 50,000 | $1.00 | $50.0K | 1 |
| 2024-08-09 | Buy | Mack Gene | CEO | 14,400 | $1.01 | $14.5K | 1 |
| 2024-07-01 | Buy | RICHMAN ERIC I | Director | 17,000 | $1.22 | $20.7K | 2 |
| 2024-03-28 | Buy | Riley Jeffrey Scott | Director | 30,000 | $3.86 | $115.8K | 1 |
| 2023-12-21 | Sell | Alder Matthias | CEO | 206 | $2.46 | $507 | 1 |
| 2023-12-07 | Sell | Alder Matthias | CEO | 1,820 | $2.50 | $4.6K | 1 |
| 2022-05-25 | Buy | RICHMAN ERIC I | CEO | 2,482 | $2.58 | $6.4K | 1 |
| 2022-05-20 | Buy | RICHMAN ERIC I | CEO | 9,256 | $2.83 | $26.2K | 1 |
| 2022-05-19 | Buy | RICHMAN ERIC I | CEO | 4,000 | $2.71 | $10.8K | 1 |
| 2022-05-19 | Buy | Calabrese Salvatore | CFO | 3,000 | $2.70 | $8.1K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Riley Jeffrey Scott | Director | $115.8K | $0 | 2024-03-28 |
| RICHMAN ERIC I | Director | $64.1K | $0 | 2024-07-01 |
| Islam Khalid | Chair | $50.0K | $0 | 2024-08-09 |
| Mack Gene | CEO | $14.5K | $0 | 2024-08-09 |
| Calabrese Salvatore | CFO | $8.1K | $0 | 2022-05-19 |
| Alder Matthias | CEO | $0 | $5.1K | 2023-12-21 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.